Showing results (121-130 of 142) with videos related to
Sort By:
Pageof 15
Nature Reviews. Clinical Oncology|January 23, 2026
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancerLiora Schultz, Kevin McNerney, Adam J Lamble, et al.Haematologica|June 13, 2024
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1Erin M Guest, John A Kairalla, Meenakshi Devidas, et al.Haematologica|April 13, 2023
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemiaJonathan A Gutman, Amanda Winters, Andrew Kent, et al.Haematologica|June 27, 2024
Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemiaMohd Minhajuddin, Amanda Winters, Haobin Ye, et al.Journal of Neuropathology and Experimental Neurology|September 2, 2017
Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous CraniopharyngiomaAndrew M Donson, John Apps, Andrea M Griesinger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and AdolescentsLucas Moreno, Steven G DuBois, Julia Glade Bender, et al.Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.Cell Stem Cell|August 22, 2020
Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem CellsCourtney L Jones, Brett M Stevens, Daniel A Pollyea, et al.Biorxiv : the Preprint Server for Biology|October 24, 2023
Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial CalciumAnagha Inguva Sheth, Krysta Engel, Hunter Tolison, et al.Pediatric Blood & Cancer|November 3, 2020
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade gliomaKaren D Wright, Xiaopan Yao, Wendy B London, et al.Pageof 15